Secretome Therapeutics, a biotechnology company advancing therapies derived from neonatal cardiac progenitor cells (nCPCs), announced the successful closing of a $20.4 million round of financing. This funding will enable initiation …
Tag:
Secretome Therapeutics, a biotechnology company advancing therapies derived from neonatal cardiac progenitor cells (nCPCs), announced the successful closing of a $20.4 million round of financing. This funding will enable initiation …
The Dallas Regional Chamber's Economic Development team serves as a single point of contact for companies, site selection consultants and corporate real estate executives examining the region for new and expanding companies.